New Method Makes Cancer Drugs Less Toxic

  • Research Stash
  • News
  • 1.6K

New Method for Controlled-Release Makes Cancer Drugs Less Toxic to Healthy Tissues

Chemotherapy is one of the most widely used treatments for cancer. It involves a single or combination of drugs that prevent cancer cells from dividing and growing. Most cancer patients who have to undergo chemotherapy treatment worry about the associated adverse side effects caused to healthy cells.

Professor Pralay Maiti with his research team at IIT BHU
Professor Pralay Maiti with his research team at IIT BHU

Scientists have been working to find ways to minimise side effects while maintaining the effectiveness of chemotherapy. A group of Indian researchers have now developed a hydrogel-based cancer treatment method.

In conventional chemotherapy, drugs being administered get diffused immediately resulting in an uncontrolled and unpredictable pattern of drug release. This burst of the drug causes damage to surrounding healthy cells. To overcome this problem, researchers have developed a superstructure of cyclodextrin and polyurethane polymer. It acts as a drug depot and releases the drug in a slow and controlled manner, increasing its efficiency.

This superstructure has been found to be friendly to biological tissues when tested in animals with an anti-cancer drug, paclitaxel. It could treat skin cancers much better when compared to the pure drug as given in chemotherapy. No side effects were observed in various biochemical parameters and histopathological tests.

“We have designed three generations of the hyperbranched structure of polymer using hydrophilic cyclodextrin and wrapped up using hydrophobic polyurethane through grafting. This special architecture handles drug release in a controlled manner.

The drug is available for its action even after three days of administration into the bloodstream as opposed to burst release of drug in conventional chemotherapy,” explained Professor Pralay Maiti of IIT (BHU), who led the research, while speaking to India Science Wire.

Injectable hydrogel solution once injected inside the body turns into solid which enhances its efficiency by localising at the tumour site. The drug and polymer superstructure interact and the balance between actions of its hydrophilic and hydrophobic layers ensures slow drug release, researchers said.

“We would like to apply this knowledge for patient care and have already filed patents. We are also trying to cure other cancers like breast, colon and other vital organ tumours,” said Prof. Maiti.

The research team included Prof. Pralay Maiti, Aparna Shukla, Akhand Pratap Singh, Tarkeshwar Dubey and Siva Hemalatha from IIT (Banaras Hindu University). The results of their research have been published in the journal ACS Applied Bio Materials. (India Science Wire)

By Yogesh Sharma

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

Rate

In conventional chemotherapy, drugs being administered get diffused immediately resulting in an uncontrolled and unpredictable pattern of drug release. This burst of the drug causes damage to surrounding healthy cells. To overcome this problem, researchers have developed a superstructure of cyclodextrin and polyurethane polymer. It acts as a drug depot and releases the drug in a slow and controlled manner, increasing its efficiency.

This superstructure has been found to be friendly to biological tissues when tested in animals with an anti-cancer drug, paclitaxel. It could treat skin cancers much better when compared to the pure drug as given in chemotherapy. No side effects were observed in various biochemical parameters and histopathological tests.

“We have designed three generations of the hyperbranched structure of polymer using hydrophilic cyclodextrin and wrapped up using hydrophobic polyurethane through grafting. This special architecture handles drug release in a controlled manner.

The drug is available for its action even after three days of administration into the bloodstream as opposed to burst release of drug in conventional chemotherapy,” explained Professor Pralay Maiti of IIT (BHU), who led the research, while speaking to India Science Wire.

Injectable hydrogel solution once injected inside the body turns into solid which enhances its efficiency by localising at the tumour site. The drug and polymer superstructure interact and the balance between actions of its hydrophilic and hydrophobic layers ensures slow drug release, researchers said.

“We would like to apply this knowledge for patient care and have already filed patents. We are also trying to cure other cancers like breast, colon and other vital organ tumours,” said Prof. Maiti.

The research team included Prof. Pralay Maiti, Aparna Shukla, Akhand Pratap Singh, Tarkeshwar Dubey and Siva Hemalatha from IIT (Banaras Hindu University). The results of their research have been published in the journal ACS Applied Bio Materials. (India Science Wire)

By Yogesh Sharma

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }
Indian Science Congress Set To Begin on Friday

Indian Science Congress Set To Begin on Friday

Imphal, capital of Manipur is all set to host the annual session of the Indian Science Congress for the first time. The Prime Minister Mr. Narendra Modi will formally inaugurate the 105th session of the Congress on Friday. Manipur University will host the science congress.

  • News
  • 1.5K
Read more
Modifications in School Bag Can Reduce Load for Children

Modifications in School Bag Can Reduce Load for Children

Heavy school bags are always a problem for school children. A group of Indian researchers has now redesigned school bag pack so that it can reduce the load on spine and shoulders of children

  • News
  • 2.6K
Read more
Scientists Find Protein Role in Tuberculosis Bacteria Growth

Scientists Find Protein Role in Tuberculosis Bacteria Growth

Researchers at the National Institute of Immunology in collaboration with CSIR- Institute of Genomics and Integrative Biology have determined the role of FtsQ, a critical cell division protein and shown that both increasing and decreasing amounts of this protein in Mycobacterium tuberculosis hampers its growth and division patterns

  • News
  • 3.4K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit